论文部分内容阅读
目的:探讨冠心苏合丸联合双联抗血小板药物防治冠心病患者PCI术后支架内再狭窄的临床疗效。方法:将符合纳入标准的72例冠心病PCI术后患者,随机分为治疗组和对照组,每组36例,对照组予以西医常规药物治疗,治疗组在其基础上联合冠心苏合丸口服,治疗6个月后比较观察两组患者临床疗效、心电图疗效及术后复查再狭窄发生率等指标。结果:治疗组临床总有效率为86.1%,高于对照组的66.7%,差异有统计学意义(P<0.05);治疗组心绞痛评分低于对照组,治疗组术后再狭窄发生率为8.3%,低于对照组的13.9%,差异均有统计学意义(P<0.05)。结论:冠心苏合丸联合双联抗血小板药物防治冠心病患者PCI术后再狭窄有较好的疗效,可改善术后心绞痛不适症状,降低术后再狭窄发生率。
Objective: To investigate the clinical efficacy of Guanxin Suhe Pills combined with dual antiplatelet drugs in the prevention and treatment of coronary stent restenosis in patients with coronary heart disease. Methods: A total of 72 patients with coronary artery disease who met the inclusion criteria were randomly divided into treatment group and control group, 36 cases in each group. The control group was treated with conventional western medicine. The treatment group was treated with Guanxin Suhema Oral, after 6 months of treatment, the clinical efficacy, electrocardiogram efficacy and the incidence of restenosis after the operation were compared. Results: The total effective rate of the treatment group was 86.1%, higher than that of the control group (66.7%), the difference was statistically significant (P <0.05). The angina score of the treatment group was lower than that of the control group. The incidence of postoperative restenosis in the treatment group was 8.3 %, Lower than 13.9% of the control group, the difference was statistically significant (P <0.05). Conclusion: Guanxin Suhewan combined with dual antiplatelet drugs in the prevention and treatment of coronary heart disease patients with restenosis after PCI has a good effect, can improve postoperative angina pectoris symptoms and reduce the incidence of postoperative restenosis.